[The effect of combination chemotherapy with cisplatin, vincristine, doxorubicin and etoposide (Tokushima-CODE: T-CODE) against lung cancer].
Yanagawa
H
H
Department of Respiratory Medicine, Tokushima Prefectural Central Hospital, Japan.
Bando
H
H
Takishita
Y
Y
Shinohara
T
T
Tanaka
H
H
D000230:Adenocarcinoma / Q000188:drug therapy; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008875:Middle Aged; D010865:Pilot Projects; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D002945:Cisplatin